Media Kit

Here you will find Oligomerix’s media kit, which includes videos and conference posters.

Oligomerix Corporate Backgrounder Winter 2020

“Therapeutic efficacy of a small molecule inhibitor targeting tau self-association in mouse models of tauopathy” (Poster at Clinical Trials on Alzheimer’s Disease Conference – November 2020)

Targeting tau protein with small molecule inhibitors for neurodegeneration – Video presentation by Oligomerix CMO Bill Erhardt, MD at the 21st International Conference on Alzheimer’s Drug Discovery presented by the Alzheimer’s Drug Discovery Foundation, October 2020.

Photo – James Moe, Ph.D., MBA, President and CEO

Photo – William Erhardt, M.D., Chief Medical Officer